SEC Company Response from GT Biopharma, Inc. (GTBP) (CIK 0000109657) (GTBP) — Jun 9, 2006

GT Biopharma, Inc. (GTBP) (CIK 0000109657)
Date: June 9, 2006 · CIK: 0000109657 · Accession: 0000109657-06-000032

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

June 5, 2006

Author

/s/

Form

CORRESP

Company

GT Biopharma, Inc. (GTBP) (CIK 0000109657)

Letter

Securities and Exchange Commission Division of Corporation Finance Attention: Gregory S. Belliston RE: OXIS International, Inc. Preliminary Schedule 14A Filed June 5, 2006 File No. 0-08092

Dear Mr. Belliston,

We hereby transmit for filing Amendment No. 1 to our Preliminary Schedule 14A (File No. 0-08092).

In addition, this cover letter is being filed on EDGAR in response to the Staff’s comment letter to us, dated June 7, 2006, in connection with our Preliminary Schedule 14A. Responses to the comment contained in the comment letter follow the text of the comments below.

1. Text of comment: Proposal No. 2, page 13: Please disclose whether you currently have any plans to issue any of the shares that would be authorized through this proposal. If you do, please describe the plans and state how many shares will be issued pursuant to each such plan.

RESPONSE: We do not have any current plans to issue any of the shares that would be authorized through the proposal referred to in the comment. Our Preliminary Schedule 14A has been amended to include a statement consistent with this response, on page 11 of the document. We are providing a marked copy of the amendment for your review.

Please do not hesitate to contact the undersigned at (650) 931-1163 or Rich Scudellari of Morrison & Foerster, LLP at (650) 813-5880 should you have any questions about the contents of this letter or the Preliminary Schedule 14A.

Sincerely,
/s/
Michael D. Centron

Show Raw Text

CORRESP
1
filename1.htm

      Correspondence

    Via
      Federal Express and Electronic Submission

    June
      8,
      2006

    Securities
      and Exchange Commission

    Division
      of Corporation Finance

    Mail-Stop
      6010

    100
      F
      Street, N.E.

    Washington,
      D.C. 20549

    Attention:
      Gregory S. Belliston

    RE: OXIS
      International, Inc.

    Preliminary
      Schedule 14A

    Filed
      June 5, 2006

    File
      No.
      0-08092

    Dear
      Mr.
      Belliston,

    We
      hereby
      transmit for filing Amendment No. 1 to our Preliminary
      Schedule 14A (File
      No.
      0-08092).

    In
      addition, this cover letter is being filed on EDGAR in response to the Staff’s
      comment letter to us, dated June 7, 2006, in connection with our Preliminary
      Schedule 14A. Responses to the comment contained in the comment letter follow
      the text of the comments below.

    1. Text
      of
      comment: Proposal
      No. 2, page 13:
      Please
      disclose whether you currently have any plans to issue any of the shares that
      would be authorized through this proposal. If you do, please describe the plans
      and state how many shares will be issued pursuant to each such
      plan.

    RESPONSE:
      We do not have any current plans to issue any of the shares that would be
      authorized through the proposal referred to in the comment. Our Preliminary
      Schedule 14A has been amended to include a statement consistent with this
      response, on page 11 of the document. We are providing a marked copy of the
      amendment for your review.

    Please
      do
      not hesitate to contact the undersigned at (650) 931-1163 or Rich Scudellari
      of
      Morrison & Foerster, LLP at (650) 813-5880 should you have any questions
      about the contents of this letter or the Preliminary Schedule 14A.

    Sincerely,

    /s/
      Michael D. Centron

                                     Michael
      D.
      Centron

                                    Vice
      President & Chief
      Financial Officer

    OXIS
      International, Inc.

              cc:

              Rich
                Scudellari, Morrison & Foerster,
                LLP

SecProbe.io